HighTower Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,218
| Closed | -$350K | – | 3015 |
|
|
2022
Q1 | $350K | Buy |
+10,218
| New | +$350K | ﹤0.01% | 2391 |
|
|
2021
Q4 | – | Sell |
-4,147
| Closed | -$225K | – | 3049 |
|
|
2021
Q3 | $225K | Buy |
+4,147
| New | +$225K | ﹤0.01% | 2613 |
|
|
2019
Q4 | – | Sell |
-11,275
| Closed | -$21K | – | 2249 |
|
|
2019
Q3 | $21K | Sell |
11,275
-637
| -5% | -$1.19K | ﹤0.01% | 2232 |
|
|
2019
Q2 | $31K | Buy |
+11,912
| New | +$31K | ﹤0.01% | 2204 |
|
|
2019
Q1 | – | Sell |
-28,540
| Closed | -$2K | – | 2168 |
|
|
2018
Q4 | $2K | Sell |
28,540
-21,875
| -43% | -$1.53K | ﹤0.01% | 2073 |
|
|
2018
Q3 | $19K | Hold |
50,415
| – | – | ﹤0.01% | 2125 |
|
|
2018
Q2 | $22K | Sell |
50,415
-7,100
| -12% | -$3.1K | ﹤0.01% | 2075 |
|
|
2018
Q1 | $135K | Sell |
57,515
-150,000
| -72% | -$352K | ﹤0.01% | 1924 |
|
|
2017
Q4 | $588K | Sell |
207,515
-23,200
| -10% | -$65.7K | ﹤0.01% | 1364 |
|
|
2017
Q3 | $659K | Sell |
230,715
-65
| -0% | -$186 | 0.01% | 1306 |
|
|
2017
Q2 | $568K | Sell |
230,780
-7,000
| -3% | -$17.2K | 0.01% | 1301 |
|
|
2017
Q1 | $858K | Sell |
237,780
-7,190
| -3% | -$25.9K | 0.01% | 1101 |
|
|
2016
Q4 | $869K | Buy |
244,970
+6,875
| +3% | +$24.4K | 0.01% | 1029 |
|
|
2016
Q3 | $959K | Sell |
238,095
-4,750
| -2% | -$19.1K | 0.01% | 935 |
|
|
2016
Q2 | $1.06M | Sell |
242,845
-4,725
| -2% | -$20.7K | 0.01% | 856 |
|
|
2016
Q1 | $940K | Buy |
247,570
+203,100
| +457% | +$771K | ﹤0.01% | 1010 |
|
|
2015
Q4 | $704K | Sell |
44,470
-804
| -2% | -$12.7K | 0.01% | 1143 |
|
|
2015
Q3 | $480K | Buy |
+45,274
| New | +$480K | 0.01% | 1221 |
|